Cart summary

You have no items in your shopping cart.

Human VEGF165 Protein, His Tag

Catalog Number: orb257924

DispatchUsually dispatched within 5-10 working days
$ 660.00
Catalog Numberorb257924
CategoryProteins
DescriptionHuman VEGF165, His Tag is expressed from human 293 cells (HEK293). It contains AA Ala 27 - Arg 191 (Accession # P15692-4).
ReactivityHuman
TagN-10×His
Form/AppearancePowder
Purity90%
ConjugationUnconjugated
MW21.1 kDa
TargetVEGF165
UniProt IDP15692
SourceHuman VEGF165, His Tag (orb257924) is expressed from human 293 cells (HEK293). It contains AA Ala 27 - Arg 191 (Accession # P15692-4).
Expression SystemHEK293
Biological OriginHuman
Biological ActivityAvastin (Bevacizumab) captured on CM5 chip via anti-human IgG Fc antibodies surface, can bind Human VEGF165 Protein, His Tag with an affinity constant of 1.03 nM as determined in a SPR assay (Biacore T200) (Routinely tested).
Expression RegionAla 27 - Arg 191
Endotoxins1.0 EU per μg
NCBINP_001165097.1
Storage-20°C to -70°C for 12 months in lyophilized state; -70°C for 3 months under sterile conditions after reconstitution. For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Buffer/PreservativesPBS, pH7.4
Alternative namesRP1-261G23.1,MGC70609,MVCD1,VEGFA,VPF
Read more...
NoteFor research use only
Application notesThis protein carries a polyhistidine tag at the N-terminus. The protein has a calculated MW of 21.1 kDa. The protein migrates as 27-28 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.
Expiration Date6 months from date of receipt.
Human VEGF165 Protein, His Tag

SDS-PAGE analysis of Human VEGF protein

Human VEGF165 Protein, His Tag

Line graph illustrates about the sensitivity range of Human VEGF protein using different concentrations

Human VEGF165 Protein, His Tag

Avastin (Bevacizumab) captured on CM5 chip via anti-human IgG Fc antibodies surface, can bind Human VEGF165 Protein, His Tag (Cat. No. orb257924) with an affinity constant of 1.03 nM as determined in a SPR assay (Biacore T200) (Routinely tested).

  • VEGF121 Protein, Human, Recombinant (His & Avi), Biotinylated [orb1960084]

    98.00%

    17 kDa (predicted). Due to glycosylation, the protein migrates to 18 kDa and 22-25 kDa under reduced (R) condition, 30 kDa and 32-40 kDa under Non reducing (N) condition based on Tris-Bis PAGE result.

    500 μg, 100 μg, 1 mg
  • VEGF121 Protein, Human, Recombinant (His & Avi) [orb1960085]

    98.00%

    17 kDa (predicted). Due to glycosylation, the protein migrates to 18 kDa and 22-25 kDa under reduced (R) condition, 30 kDa and 32-40 kDa under Non reducing (N) condition based on Tris-Bis PAGE result.

    500 μg, 100 μg, 1 mg
  • VEGF165 Protein, Human, Recombinant (His & Avi) [orb1960086]

    > 95%

    22.2 kDa (predicted). Due to glycosylation, the protein migrates to 28-35 kDa under reduced (R) condition, 45-60 kDa under Non reducing (N) condition based on Tris-Bis PAGE result.

    1 mg, 100 μg, 500 μg
  • VEGF165 Protein, Human, Recombinant (His & Avi), FITC-Labeled [orb1960087]

    > 95%

    22.2 kDa (predicted). Due to glycosylation, the protein migrates to 28-33 kDa under reduced (R) condition, 45-55 kDa under Non reducing (N) condition based on Tris-Bis PAGE result.

    1 mg, 500 μg, 100 μg
  • VEGF165 Protein, Human, Recombinant (His & Avi), Biotinylated [orb1954860]

    98.10%

    23.1 kDa (predicted); 28.3 kDa (reducing condition, due to glycosylation)

    20 μg, 100 μg, 200 μg, 500 μg